TG Therapeutics sees launching in Q1 of 2023 and says that "ideally" Briumvi will be available in centers within 30 to 45 days of the start of the year. Comments from TG Therapeutics’ Briumvi FDA approval call.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on TGTX: